2021

1. A growth modulation index-based geistra score as a new prognostic tool for trabectedin efficacy in patients with advanced soft tissue sarcomas: A Spanish group for sarcoma research (GEIS) retrospective study

   Cancers, Vol. 13, Núm. 4, pp. 1-15